Bharati Devi Kochar, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Inflammatory Bowel Diseases | 36 | 2024 | 2421 | 7.430 |
Why?
|
Colitis, Ulcerative | 18 | 2024 | 1919 | 2.770 |
Why?
|
Crohn Disease | 14 | 2023 | 2275 | 1.870 |
Why?
|
Gastrointestinal Agents | 4 | 2022 | 509 | 1.420 |
Why?
|
Proctocolectomy, Restorative | 5 | 2023 | 190 | 1.190 |
Why?
|
Internet | 3 | 2024 | 3078 | 1.020 |
Why?
|
Gastroenterology | 2 | 2022 | 571 | 0.960 |
Why?
|
Polypharmacy | 3 | 2024 | 307 | 0.940 |
Why?
|
Short Bowel Syndrome | 2 | 2018 | 353 | 0.920 |
Why?
|
Colonic Pouches | 2 | 2023 | 122 | 0.750 |
Why?
|
Depressive Disorder | 3 | 2018 | 3726 | 0.740 |
Why?
|
Pouchitis | 4 | 2023 | 64 | 0.730 |
Why?
|
Esophagitis | 1 | 2021 | 163 | 0.680 |
Why?
|
Meningitis | 1 | 2021 | 218 | 0.660 |
Why?
|
Videoconferencing | 1 | 2021 | 203 | 0.630 |
Why?
|
Pyoderma Gangrenosum | 1 | 2018 | 84 | 0.580 |
Why?
|
Telephone | 1 | 2021 | 624 | 0.580 |
Why?
|
Geriatrics | 1 | 2022 | 387 | 0.570 |
Why?
|
Opportunistic Infections | 1 | 2020 | 377 | 0.560 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 2 | 2023 | 506 | 0.560 |
Why?
|
Eosinophilic Esophagitis | 2 | 2018 | 191 | 0.530 |
Why?
|
Peptides | 2 | 2018 | 4354 | 0.510 |
Why?
|
Proton Pump Inhibitors | 2 | 2023 | 551 | 0.500 |
Why?
|
Colitis | 2 | 2020 | 1229 | 0.490 |
Why?
|
Esophageal Diseases | 1 | 2015 | 168 | 0.470 |
Why?
|
Immunocompromised Host | 1 | 2020 | 857 | 0.470 |
Why?
|
Colonic Neoplasms | 2 | 2023 | 2526 | 0.460 |
Why?
|
Exophthalmos | 1 | 2015 | 97 | 0.450 |
Why?
|
Cavernous Sinus | 1 | 2015 | 123 | 0.450 |
Why?
|
Immunologic Factors | 2 | 2021 | 1588 | 0.430 |
Why?
|
Pancreatitis | 2 | 2023 | 1100 | 0.410 |
Why?
|
Immunosuppressive Agents | 3 | 2021 | 4167 | 0.410 |
Why?
|
Pyrroles | 1 | 2018 | 1137 | 0.400 |
Why?
|
Carotid Artery, Internal | 1 | 2015 | 438 | 0.400 |
Why?
|
Arteriovenous Fistula | 1 | 2015 | 314 | 0.390 |
Why?
|
Mass Media | 2 | 2024 | 300 | 0.380 |
Why?
|
Piperidines | 2 | 2022 | 1650 | 0.370 |
Why?
|
Eosinophilia | 1 | 2015 | 559 | 0.360 |
Why?
|
Quality of Life | 4 | 2024 | 13308 | 0.350 |
Why?
|
Humans | 65 | 2024 | 760613 | 0.350 |
Why?
|
Ambulatory Care | 1 | 2021 | 2782 | 0.340 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1864 | 0.320 |
Why?
|
Aged | 24 | 2024 | 169143 | 0.320 |
Why?
|
Depression | 6 | 2020 | 8045 | 0.310 |
Why?
|
Patient Selection | 2 | 2021 | 4279 | 0.310 |
Why?
|
Biological Products | 3 | 2022 | 916 | 0.300 |
Why?
|
Thrombosis | 1 | 2022 | 3051 | 0.290 |
Why?
|
Pyrimidines | 2 | 2022 | 3016 | 0.290 |
Why?
|
Vision Disorders | 1 | 2015 | 1084 | 0.290 |
Why?
|
Colorectal Neoplasms | 3 | 2023 | 6853 | 0.280 |
Why?
|
Antihypertensive Agents | 1 | 2015 | 2061 | 0.240 |
Why?
|
Cohort Studies | 8 | 2022 | 41337 | 0.240 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2022 | 4356 | 0.220 |
Why?
|
Stents | 2 | 2023 | 3303 | 0.220 |
Why?
|
Telemedicine | 1 | 2021 | 3018 | 0.220 |
Why?
|
Adult | 23 | 2024 | 220007 | 0.220 |
Why?
|
Parenteral Nutrition | 2 | 2018 | 656 | 0.210 |
Why?
|
Cholinergic Antagonists | 1 | 2024 | 164 | 0.210 |
Why?
|
Cost of Illness | 3 | 2023 | 1940 | 0.200 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5640 | 0.200 |
Why?
|
Frail Elderly | 2 | 2024 | 752 | 0.200 |
Why?
|
Retrospective Studies | 14 | 2024 | 80345 | 0.200 |
Why?
|
Prevalence | 4 | 2024 | 15686 | 0.190 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15840 | 0.190 |
Why?
|
Anti-Inflammatory Agents | 2 | 2021 | 1796 | 0.190 |
Why?
|
Inappropriate Prescribing | 1 | 2024 | 209 | 0.190 |
Why?
|
Comorbidity | 5 | 2023 | 10553 | 0.190 |
Why?
|
Biological Therapy | 1 | 2022 | 139 | 0.190 |
Why?
|
Male | 25 | 2024 | 359718 | 0.190 |
Why?
|
Middle Aged | 19 | 2024 | 220359 | 0.180 |
Why?
|
Age Factors | 5 | 2024 | 18413 | 0.180 |
Why?
|
Los Angeles | 1 | 2021 | 243 | 0.180 |
Why?
|
United States | 13 | 2023 | 72448 | 0.180 |
Why?
|
Incidence | 6 | 2023 | 21391 | 0.180 |
Why?
|
Female | 26 | 2024 | 391246 | 0.170 |
Why?
|
Registries | 1 | 2016 | 8458 | 0.170 |
Why?
|
Treatment Outcome | 9 | 2024 | 64981 | 0.170 |
Why?
|
Patient Readmission | 3 | 2018 | 3322 | 0.160 |
Why?
|
Insurance, Life | 1 | 2018 | 14 | 0.160 |
Why?
|
Young Adult | 11 | 2024 | 58748 | 0.160 |
Why?
|
Anastomosis, Surgical | 2 | 2022 | 983 | 0.160 |
Why?
|
Flatulence | 1 | 2017 | 19 | 0.150 |
Why?
|
Feces | 1 | 2024 | 1455 | 0.150 |
Why?
|
Health Care Costs | 2 | 2023 | 3258 | 0.150 |
Why?
|
Histocytochemistry | 1 | 2018 | 700 | 0.150 |
Why?
|
Risk Factors | 9 | 2024 | 74333 | 0.140 |
Why?
|
Postoperative Complications | 2 | 2024 | 15679 | 0.140 |
Why?
|
Denmark | 1 | 2019 | 760 | 0.140 |
Why?
|
Insurance | 1 | 2018 | 114 | 0.140 |
Why?
|
Gases | 1 | 2017 | 203 | 0.140 |
Why?
|
Syndrome | 1 | 2023 | 3280 | 0.140 |
Why?
|
Pancreatic Diseases | 1 | 2018 | 343 | 0.130 |
Why?
|
Aged, 80 and over | 6 | 2021 | 58980 | 0.130 |
Why?
|
Hospitalization | 4 | 2024 | 10789 | 0.130 |
Why?
|
Social Participation | 1 | 2017 | 183 | 0.130 |
Why?
|
Time Factors | 6 | 2021 | 40139 | 0.130 |
Why?
|
Levobunolol | 1 | 2015 | 3 | 0.130 |
Why?
|
Fecal Incontinence | 1 | 2017 | 241 | 0.120 |
Why?
|
Liver Cirrhosis | 2 | 2022 | 1931 | 0.120 |
Why?
|
Drug Utilization | 1 | 2021 | 1195 | 0.120 |
Why?
|
Anxiety | 3 | 2020 | 4538 | 0.120 |
Why?
|
Nausea | 1 | 2017 | 678 | 0.120 |
Why?
|
Multivariate Analysis | 4 | 2021 | 12159 | 0.120 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 25941 | 0.110 |
Why?
|
Dilatation | 1 | 2015 | 307 | 0.110 |
Why?
|
Ophthalmic Solutions | 1 | 2015 | 304 | 0.110 |
Why?
|
Esophagoscopy | 1 | 2015 | 390 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 10343 | 0.110 |
Why?
|
Adolescent | 12 | 2024 | 87809 | 0.110 |
Why?
|
Logistic Models | 4 | 2021 | 13312 | 0.110 |
Why?
|
Personal Satisfaction | 1 | 2017 | 643 | 0.110 |
Why?
|
Quinoxalines | 1 | 2015 | 297 | 0.100 |
Why?
|
Constipation | 1 | 2017 | 561 | 0.100 |
Why?
|
Antibodies | 1 | 2021 | 2421 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1869 | 0.100 |
Why?
|
Regression Analysis | 2 | 2021 | 6359 | 0.100 |
Why?
|
Digestive System Surgical Procedures | 1 | 2017 | 575 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2021 | 4899 | 0.100 |
Why?
|
Deglutition Disorders | 1 | 2017 | 626 | 0.100 |
Why?
|
Abdominal Pain | 1 | 2017 | 1063 | 0.090 |
Why?
|
Risk Assessment | 2 | 2024 | 24102 | 0.090 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39262 | 0.090 |
Why?
|
Medical Records | 1 | 2016 | 1407 | 0.090 |
Why?
|
Information Storage and Retrieval | 1 | 2016 | 822 | 0.090 |
Why?
|
Diarrhea | 1 | 2017 | 1319 | 0.090 |
Why?
|
Minority Groups | 1 | 2017 | 1201 | 0.090 |
Why?
|
Steroids | 1 | 2015 | 928 | 0.090 |
Why?
|
Thiophenes | 1 | 2015 | 587 | 0.090 |
Why?
|
Age of Onset | 1 | 2017 | 3302 | 0.090 |
Why?
|
Fatigue | 1 | 2017 | 1544 | 0.090 |
Why?
|
Gastroesophageal Reflux | 1 | 2017 | 816 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1189 | 0.090 |
Why?
|
Liver Diseases | 1 | 2018 | 1302 | 0.090 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 12968 | 0.080 |
Why?
|
Remission Induction | 1 | 2015 | 2392 | 0.080 |
Why?
|
Odds Ratio | 2 | 2021 | 9716 | 0.080 |
Why?
|
Cerebral Angiography | 1 | 2015 | 1274 | 0.080 |
Why?
|
Intraocular Pressure | 1 | 2015 | 1288 | 0.080 |
Why?
|
Intestines | 1 | 2017 | 1907 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2021 | 22052 | 0.080 |
Why?
|
Hyperplasia | 2 | 2021 | 1155 | 0.080 |
Why?
|
Reoperation | 1 | 2018 | 4289 | 0.070 |
Why?
|
Cognition | 2 | 2023 | 6964 | 0.070 |
Why?
|
Ileum | 2 | 2023 | 555 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12531 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2019 | 2890 | 0.070 |
Why?
|
Health Status | 1 | 2020 | 4082 | 0.070 |
Why?
|
Self Report | 1 | 2017 | 3711 | 0.070 |
Why?
|
Disease Progression | 1 | 2023 | 13505 | 0.070 |
Why?
|
Health Expenditures | 1 | 2018 | 2362 | 0.070 |
Why?
|
Recurrence | 1 | 2017 | 8483 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16548 | 0.060 |
Why?
|
Sulfonamides | 1 | 2015 | 1977 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11070 | 0.060 |
Why?
|
Skin | 1 | 2018 | 4466 | 0.060 |
Why?
|
Prognosis | 4 | 2019 | 29661 | 0.060 |
Why?
|
Prospective Studies | 5 | 2023 | 54306 | 0.060 |
Why?
|
Smoking | 1 | 2021 | 9073 | 0.060 |
Why?
|
Length of Stay | 1 | 2017 | 6476 | 0.060 |
Why?
|
Geriatric Assessment | 2 | 2022 | 1405 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7408 | 0.050 |
Why?
|
Colonoscopy | 2 | 2021 | 1387 | 0.050 |
Why?
|
Medicare | 1 | 2021 | 6785 | 0.050 |
Why?
|
Child, Preschool | 3 | 2022 | 42056 | 0.050 |
Why?
|
Quality Improvement | 1 | 2018 | 3835 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3386 | 0.050 |
Why?
|
Colon | 2 | 2023 | 1788 | 0.050 |
Why?
|
I-kappa B Proteins | 1 | 2002 | 212 | 0.050 |
Why?
|
Child | 5 | 2020 | 79799 | 0.050 |
Why?
|
Metagenome | 1 | 2024 | 450 | 0.050 |
Why?
|
Research Design | 1 | 2016 | 6180 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2020 | 26179 | 0.040 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 298 | 0.040 |
Why?
|
Biopsy | 2 | 2021 | 6771 | 0.040 |
Why?
|
Cholangitis, Sclerosing | 1 | 2021 | 177 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15286 | 0.040 |
Why?
|
Infant | 1 | 2020 | 36053 | 0.040 |
Why?
|
Independent Living | 1 | 2022 | 570 | 0.040 |
Why?
|
Diet | 1 | 2015 | 8010 | 0.040 |
Why?
|
Phylogeny | 1 | 2024 | 2775 | 0.030 |
Why?
|
Hospital Charges | 1 | 2017 | 359 | 0.030 |
Why?
|
NF-kappa B | 1 | 2002 | 2486 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2002 | 2907 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2016 | 939 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2023 | 1888 | 0.030 |
Why?
|
Acute Disease | 1 | 2024 | 7268 | 0.030 |
Why?
|
Bacteria | 1 | 2024 | 2199 | 0.030 |
Why?
|
Needs Assessment | 1 | 2018 | 1139 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2021 | 3734 | 0.030 |
Why?
|
Databases, Factual | 2 | 2017 | 8022 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2017 | 894 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6065 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20509 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3364 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1399 | 0.020 |
Why?
|
Neutrophils | 1 | 2002 | 3767 | 0.020 |
Why?
|
Genotype | 1 | 2024 | 12957 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2022 | 7022 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2501 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9288 | 0.020 |
Why?
|
Apoptosis | 1 | 2002 | 9497 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10546 | 0.020 |
Why?
|
Animals | 1 | 2018 | 167960 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 9591 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7805 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10755 | 0.010 |
Why?
|
Neutrophil Activation | 1 | 2002 | 181 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2002 | 435 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5397 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9406 | 0.010 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2002 | 542 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11902 | 0.010 |
Why?
|
Cytoplasm | 1 | 2002 | 1516 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 12628 | 0.010 |
Why?
|
Monocytes | 1 | 2002 | 2575 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2002 | 18955 | 0.000 |
Why?
|